Article
Review of the Fluoropyrimidine Antidote Uridine Triacetate
2024-09-02
Abstract excerpt
not-yet-known not-yet-known not-yet-known unknown In 2015, the United States Food and Drug Administration (FDA) approved uridine triacetate to treat overdose and severe toxicity of the fluoropyrimidine chemotherapy agents 5-fluorouracil (5-FU) and its oral prodrug capecitabine. Uridine triacetate is as an oral prodrug of uridine which competes with cytotoxic fluoropyrimidine metabolites for incorporation into...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a8aa8b44-b917-5a46-afe8-5875f1986ee5
- DOI
- 10.22541/au.172526739.97846727/v1
